9789352706808 - novel insights on sglt-2 inhibitors di chawla, rajeev; jaggi, shalini (12 risultati)

Condizione: New.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Condizione: New. SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes mellitus.This book is a concise guide to the use of SGLT2 inhibitors for the treatment of diabetes.Beginning with an overview of the evolution and physiology of SGLT2 inhibitors, the following sections cover the renal, cardiovascular, and metabolic and haemodynamic effects of their use. Adverse effects are also examined.The book concludes with detailed discussion on SGLT2 inhibitor use as a preferred option for management of type 2 diabetes, and currently emerging data for their successful use for treatment of type 1 diabetes.Authored by recognised experts in the field, the book provides clinicians with the latest advances in the field, further enhanced by illustrations and figures to assist learning.Key pointsConcise guide to use of SGLT2 inhibitors for management of diabetesCovers common use for treatment of type 2 diabetes as well as increasing use for type 1 diabetesIn depth discussion on associated systemic effectsHighly illustrated with diagrams and figures.…

Condizione: As New. Unread book in perfect condition.

PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Condizione: new. Paperback. SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes mellitus.This book is a concise guide to the use of SGLT2 inhibitors for the treatment of diabetes.Beginning with an overview of the evolution and physiology of SGLT2 inhibitors, the following sections cover the renal, cardiovascular, and metabolic and haemodynamic effects of their use. Adverse effects are also examined.The book concludes with detailed discussion on SGLT2 inhibitor use as a preferred option for management of type 2 diabetes, and currently emerging data for their successful use for treatment of type 1 diabetes.Authored by recognised experts in the field, the book provides clinicians with the latest advances in the field, further enhanced by illustrations and figures to assist learning.Key pointsConcise guide to use of SGLT2 inhibitors for management of diabetesCovers common use for treatment of type 2 diabetes as well as increasing use for type 1 diabetesIn depth discussion on associated systemic effectsHighly illustrated with diagrams and figures Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Condizione: New. In English.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New. Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have.

Paperback. Condizione: new. Paperback. SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes mellitus.This book is a concise guide to the use of SGLT2 inhibitors for the treatment of diabetes.Beginning with an overview of the evolution and physiology of SGLT2 inhibitors, the following sections cover the renal, cardiovascular, and metabolic and haemodynamic effects of their use. Adverse effects are also examined.The book concludes with detailed discussion on SGLT2 inhibitor use as a preferred option for management of type 2 diabetes, and currently emerging data for their successful use for treatment of type 1 diabetes.Authored by recognised experts in the field, the book provides clinicians with the latest advances in the field, further enhanced by illustrations and figures to assist learning.Key pointsConcise guide to use of SGLT2 inhibitors for management of diabetesCovers common use for treatment of type 2 diabetes as well as increasing use for type 1 diabetesIn depth discussion on associated systemic effectsHighly illustrated with diagrams and figures Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

Paperback. Condizione: New. SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium-glucose transport protein 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes mellitus.This book is a concise guide to the use of SGLT2 inhibitors for the treatment of diabetes.Beginning with an overview of the evolution and physiology of SGLT2 inhibitors, the following sections cover the renal, cardiovascular, and metabolic and haemodynamic effects of their use. Adverse effects are also examined.The book concludes with detailed discussion on SGLT2 inhibitor use as a preferred option for management of type 2 diabetes, and currently emerging data for their successful use for treatment of type 1 diabetes.Authored by recognised experts in the field, the book provides clinicians with the latest advances in the field, further enhanced by illustrations and figures to assist learning.Key pointsConcise guide to use of SGLT2 inhibitors for management of diabetesCovers common use for treatment of type 2 diabetes as well as increasing use for type 1 diabetesIn depth discussion on associated systemic effectsHighly illustrated with diagrams and figures.…